By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Immunomedics, Inc. 

300 American Road

Morris Plains  New Jersey  07950-2450  U.S.A.
Phone: 201-605-8200 Fax: 973-605-8282



Company News
Immunomedics To Present First Clinical Results With Anti-HLA-DR Antibody For Treatment Of Hematologic Malignancies At The 2015 Annual Meeting Of The American Society of Hematology 12/1/2015 10:20:43 AM
Immunomedics, Inc. (IMMU) Reports Improved Progression-Free Survival Results With Sacituzumab Govitecan In Triple-Negative Breast Cancer 11/9/2015 8:13:09 AM
Immunomedics, Inc. (IMMU) Announces Sacituzumab Govitecan Is Synergistic With Chemotherapeutics That Target Cell Division In Triple-Negative Breast Cancer 11/9/2015 7:54:22 AM
Immunomedics, Inc. (IMMU) Announces First Quarter Fiscal 2016 Results And Clinical Program Developments 11/5/2015 6:46:44 AM
Immunomedics, Inc. (IMMU) Announces Conference Call And Webcast For First Quarter Fiscal 2016 Financial Results 10/29/2015 9:24:59 AM
Immunomedics, Inc. (IMMU) Reports Durable Responses In Patients With Advanced Solid Cancers After Therapy With Sacituzumab Govitecan 10/20/2015 7:28:34 AM
Immunomedics, Inc. (IMMU) Reports Interim Phase II Results With Sacituzumab Govitecan In Lung Cancers 9/8/2015 7:57:49 AM
Immunomedics, Inc. (IMMU) To Present At Upcoming Investor Conferences 9/2/2015 7:29:21 AM
Immunomedics, Inc. (IMMU) Appoints Arthur S. Kirsch As Director 8/19/2015 7:50:30 AM
Immunomedics, Inc. (IMMU) Extends U.S. Patent Protection For Antibody-Drug Conjugate Program To 2033 8/18/2015 8:16:24 AM